Scholars Central

Conference abstractPublished 20 Oct 2014

A protocadherin that crosstalks with the androgen receptor axis to control neuroendocrine transdifferentiation in human prostate cancer

Authors: Stéphane Terry

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Castration-resistant prostate cancers that relapse after androgen deprivation therapies are overwhelmingly responsible for the mortality from prostate cancer. These tumors progress despite castrate androgen levels and respond poorly to most therapeutics including chemotherapy. Although mechanisms enabling recurrent activity of Androgen Receptor (AR) are certainly involved in the growth of castrate resistant tumors, how these tumors convert from a hormone-sensitive to a castrate resistant phenotype remains unclear. Protocadherin-PC (PCDH-PC) is a putative androgen-repressed gene on the Y-chromosome, and a potential marker of apoptosis-resistance and neuroendocrine phenotype in the commonly used prostate cancer cell line, LNCaP. In recent investigations, we explored the dynamic expression pattern of PCDH-PC following androgen deprivation in human prostate cancer specimens as well as in cultures of LNCaP cells. Potential relationships between Androgen Receptor (AR), PCDH-PC and NE differentiation were also studied in various cell lines as well as their sensitivity to chemotherapeutic agents. PCDH-PC expression as being especially up-regulated in short-term hormonally treated tumors and in cell cultures in association with increased NE differentiation was found. Furthermore, acquisition of an NE phenotype by prostate cancer cells correlated with the emergence of a chemoresistant state. Finally, it was found that androgen regulates the expression of PCDH-PC and that PCDH-PC inversely modulated the ligand-dependent AR transcriptional activity, thereby regulating the neuroendocrine phenotype in prostate cancer cells. Together these results suggest that PCDH-PC can serve as an early marker for the transition of prostate cancer from epithelial to neuroendocrine phenotype and support a model of transdiffentiation/adaptive mechanism as an important step towards chemohormonal resistance.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEndocrinology & Metabolic Syndrome
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Stéphane Terry”